au.\*:("ALTAMURA, C")
Results 1 to 15 of 15
Selection :
NOXIPTYLIN AND MASKED DEPRESSIONSACCHETTI E; SMERALDI E; BELLODI L et al.1978; AGRESSOLOGIE; FRA; DA. 1978; VOL. 19; NO 1; PP. 59-63; ABS. FRE; BIBL. 26 REF.Article
Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer's diseaseMAES, M; DEVOS, N; VANDENBROUCKE, M et al.Journal of psychiatric research. 1999, Vol 33, Num 5, pp 397-405, issn 0022-3956Article
Linear CT-scan measurements in alcohol-dependent patients with and without delirium tremensMAES, M; VANDOOLAEGHE, E; DEGROOTE, J et al.Alcohol (Fayetteville, NY). 2000, Vol 20, Num 2, pp 117-123, issn 0741-8329Article
The inflammatory response system in treatment-resistant schizophrenia : Increased serum interleukin-6LIN, A; KENIS, G; BIGNOTTI, S et al.Schizophrenia research. 1998, Vol 32, Num 1, pp 9-15, issn 0920-9964Article
Effects of pregnancy and delivery on serum prolyl endopeptidase (PEP) activity : alterations in serum PEP are related to increased anxiety in the early puerperium and to postpartum depressionMAES, M; LIBBRECHT, I; SCHARPE, S et al.Journal of affective disorders. 2000, Vol 57, Num 1-3, pp 125-137, issn 0165-0327Article
Lowered ω3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patientsMAES, M; CHRISTOPHE, A; DELANGHE, J et al.Psychiatry research. 1999, Vol 85, Num 3, pp 275-291, issn 0165-1781Article
High frequency repetitive transcranial magnetic stimulation decreases cerebral vasomotor reactivityVERNIERI, F; MAGGIO, P; TIBUZZI, F et al.Clinical neurophysiology. 2009, Vol 120, Num 6, pp 1188-1194, issn 1388-2457, 7 p.Article
Parsing the clinical phenotype of depression : the need to integrate brief depressive episodesANGST, J; GAMMA, A; PEZAWAS, L et al.Acta psychiatrica Scandinavica. 2007, Vol 115, Num 3, pp 221-228, issn 0001-690X, 8 p.Article
Lower serum zinc in relation to serum albumin and proinflammatory cytokines in detoxified alcohol-dependent patients without apparent liver diseaseDE VOS, N; CAI SONG; MAES, M et al.Neuropsychobiology. 1999, Vol 39, Num 3, pp 144-150, issn 0302-282XArticle
Dexamethasone suppression test in positive and negative schizophreniaALTAMURA, C; GUERCETTI, G; PERCUDANI, M et al.Psychiatry research. 1989, Vol 30, Num 1, pp 69-75, issn 0165-1781Article
PHARMACOKINETICS OF AMITRIPTYLINE IN THE ELDERLYHENRY JF; ALTAMURA C; GOMENI R et al.1981; INT. J. CLIN. PHARMACOL. THER. TOXICOL.; DEU; DA. 1981; VOL. 19; NO 1; PP. 1-5; BIBL. 1 P.Article
Haloperidol decanoate in chronic schizophrenia: a study of 12 months with plasma levelsALTAMURA, C. A; COLACURCIO, F; MAURI, M. C et al.Progress in neuro-psychopharmacology & biological psychiatry. 1990, Vol 14, Num 1, pp 25-35, issn 0278-5846Article
Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophreniaBOIN, F; ZANARDINI, R; PIOLI, R et al.Molecular psychiatry. 2001, Vol 6, Num 1, pp 79-82, issn 1359-4184Article
L-sulpiride in young and elderly negative schizophrenics : clinical and pharmacokinetic variablesMAURI, M. C; LEVA, P; COPPOLA, M. T et al.Progress in neuro-psychopharmacology & biological psychiatry. 1994, Vol 18, Num 2, pp 355-366, issn 0278-5846Article
Plasma and platelet excitatory amino acids in psychiatric disordersALTAMURA, C. A; MAURI, M. C; FERRARA, A et al.The American journal of psychiatry. 1993, Vol 150, Num 11, pp 1731-1733, issn 0002-953XArticle